Information to be added soon. 

Al-Ahmari et al., (2010) reviewed 11 patients with GS who received allogeneic hematopoietic stem cell transplant (aHSCT) between 1993 and 2007. The median age at transplantation was 8.2 months. Seven patients treated with chemotherapy before transplantation because they reached accelerated phase. Two sources of grafts were available; matched-related marrows in 8 patients and mismatched unrelated cords in the remaining three. The median time for engraftment in all subjects was fifteen days. Ten patients were alive at a median age of 4.8 years after transplantation. One patient died of septic shock 6 months after transplantation. The authors concluded that early aHSCT is feasible for treating patients with Griscelli syndrome and low level of donor cell engraftment is sufficient to prevent the recurrence of the disease.